Gastric cancer
Conditions
Interventions
Gold Standard:Pathological examination
Index test:A fusion machine learning model based on radiomics and clinical features before neoadjuvant immunotherapy
Sponsors
The First Medical Center of Chinese PLA General Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1. Pathological diagnosis of gastric adenocarcinoma; 2. Adapt to neoadjuvant immunotherapy; 3. No distant metastasis occurred; 4. Complete clinicopathological information can be collected.
Exclusion criteria
Exclusion criteria: 1. Received other previous treatments, such as radiotherapy, targeted therapy, or chemotherapy alone; 2. Missing baseline enhanced CT intravenous images before neoadjuvant immunotherapy or poor image quality.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Area Under the Curve;Sensitivity;Specificity; | — |
Secondary
| Measure | Time frame |
|---|---|
| F1 score; | — |
Countries
China
Contacts
Public ContactWei Bo
The First Medical Center of Chinese PLA General Hospital
Outcome results
None listed